Autonomix Medical (NASDAQ:AMIX) Announces Quarterly Earnings Results, Beats Estimates By $0.11 EPS

Autonomix Medical (NASDAQ:AMIX) posted its quarterly earnings results on Tuesday. The company reported ($2.51) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.62) by $0.11, FiscalAI reports.

Autonomix Medical Stock Up 14.4%

NASDAQ AMIX traded up $0.24 during trading hours on Tuesday, hitting $1.94. The company had a trading volume of 57,861,297 shares, compared to its average volume of 1,541,146. Autonomix Medical has a fifty-two week low of $1.46 and a fifty-two week high of $32.55. The business has a fifty day simple moving average of $3.32 and a 200-day simple moving average of $6.56. The firm has a market cap of $1.89 million, a P/E ratio of -0.05 and a beta of -0.70.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Autonomix Medical in a report on Monday, October 26th. Wall Street Zen upgraded shares of Autonomix Medical from a “strong sell” rating to a “sell” rating in a research note on Saturday, October 3rd. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Autonomix Medical has a consensus rating of “Hold” and an average target price of $42.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc is a medical device company developing catheter-based technologies for the detection and treatment of conditions involving the peripheral nervous system. The company’s platform is designed to identify neural signals in real time, with the goal of helping physicians locate and selectively treat targeted nerves during minimally invasive procedures.

Autonomix’s lead development program is focused on pain associated with pancreatic cancer. Its technology is intended to support targeted nerve ablation, potentially offering an alternative approach for managing pain while reducing the need for more extensive procedures.